ELIXIRON
LIVE

Serial Number

50102702

Owner

ELIXIRON IMMUNOTHERAPEUTICS INC.

Attorney

Michael T. Smith

Filing Date

Sep 11, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ELIXIRON Trademark

Serial Number: 50102702

ELIXIRON is a trademark filed by ELIXIRON IMMUNOTHERAPEUTICS INC. on September 11, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ELIXIRON IMMUNOTHERAPEUTICS INC.

16 F.-3, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.,
Taipei City 115011 R.O.C. , TW

Entity Type: 03

Trademark Details

Filing Date

September 11, 2026

Registration Date

Not Registered

Goods & Services

Scientific research in the field of immunology; Scientific research in the field of neurodegeneration; Conducting clinical trials for others; Clinical research services; Research and development of antibodies; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical reagents; Culturing of cells for others for scientific research purposes; Research and development of new products for others; Research and development of medicines; Technological research in the field of immunology; Scientific laboratory services; Scientific research; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of clinical research; Medical research in the field of antibodies; Technological research in the field of neurodegeneration

Pharmaceutical preparations for the treatment of Alzheimer’s disease; Pharmaceutical preparations for the treatment of vitiligo; Pharmaceutical preparations for the treatment of hemophagocytic syndrome; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of ALS (Amyotrophic Lateral Sclerosis); Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of immune diseases; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of liver cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for suppressing tumors

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 11, 2026 MAFR
NEW APPLICATION ENTERED
Sep 11, 2026 NWAP